|
RAB2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.56350000513461E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.94230004197027E-09 |
| Normal-vs-Stage2 |
8.675300E-03 |
| Normal-vs-Stage3 |
1.778160E-03 |
| Normal-vs-Stage4 |
1.202230E-02 |
| Stage1-vs-Stage2 |
4.542600E-01 |
| Stage1-vs-Stage3 |
8.038000E-02 |
| Stage1-vs-Stage4 |
4.451800E-02 |
| Stage2-vs-Stage3 |
6.410000E-01 |
| Stage2-vs-Stage4 |
4.465200E-01 |
| Stage3-vs-Stage4 |
6.998800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.70180000039311E-07 |
| Normal-vs-AfricanAmerican |
2.765300E-04 |
| Normal-vs-Asian |
2.01180000003465E-06 |
| Caucasian-vs-AfricanAmerican |
6.382200E-01 |
| Caucasian-vs-Asian |
4.849700E-02 |
| AfricanAmerican-vs-Asian |
5.233600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52951999999873E-05 |
| Normal-vs-Female |
1.76059999912326E-08 |
| Male-vs-Female |
5.938300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.143030E-01 |
| Normal-vs-Age(41-60Yrs) |
6.71500000049008E-09 |
| Normal-vs-Age(61-80Yrs) |
8.45560000000134E-05 |
| Normal-vs-Age(81-100Yrs) |
7.772400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.747230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.718400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.603000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.024100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.858800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.847800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.18391971174015E-12 |
| Normal-vs-Grade 2 |
2.40020003872132E-09 |
| Normal-vs-Grade 3 |
4.985200E-04 |
| Normal-vs-Grade 4 |
4.793900E-02 |
| Grade 1-vs-Grade 2 |
1.499730E-03 |
| Grade 1-vs-Grade 3 |
1.17060000004443E-06 |
| Grade 1-vs-Grade 4 |
3.90969999997104E-06 |
| Grade 2-vs-Grade 3 |
3.982500E-03 |
| Grade 2-vs-Grade 4 |
1.126140E-02 |
| Grade 3-vs-Grade 4 |
5.338000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.02855526715484E-12 |
| Normal-vs-ccB subtype |
1.454490E-02 |
| ccA subtype-vs-ccB subtype |
1.47179999998581E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.79110000018279E-07 |
| Normal-vs-N1 |
3.459200E-01 |
| N0-vs-N1 |
4.609900E-04 |
|
|
